NewAmsterdam Pharma (NAMS) Stock Forecast & Price Target

4 days ago · According to the 6 analysts' twelve-month price targets for NewAmsterdam Pharma, the average price target is $41.60. The highest price target for NAMS is $48.00, while the lowest price target for NAMS is $36.00. The average price target represents a forecasted upside of …

CouponFollow Extension

$41.60
OFF

NewAmsterdam Pharma (NAMS) Stock Forecast & Price Target

3 weeks from now

marketbeat.com

$30
OFF

What Is The Current Price Target And Forecast For NewAmsterdam …

3 weeks from now

6 days ago · The forecasts for NewAmsterdam Pharma Company N.V. (NAMS) range from a low of $30 to a high of $48. The average price target represents a increase of $88.54 from the last …

zacks.com

$41.33
OFF

Newamsterdam Pharma Co Nv Stock Forecast & Predictions: 1Y …

3 weeks from now

According to . 6 Wall Street analysts that have issued a 1 year NAMS price target, the average NAMS price target is $41.33, with the highest NAMS stock price forecast at $48.00 and the …

wallstreetzen.com

$48.00
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Stock, Analyst Ratings, …

3 weeks from now

The latest price target for NewAmsterdam Pharma (NASDAQ:NAMS) was reported by HC Wainwright & Co. on January 14, 2025. The analyst firm set a price target for $48.00 expecting …

benzinga.com

$40.88
OFF

Deep Dive Into NewAmsterdam Pharma Stock: Analyst …

3 weeks from now

Jan 24, 2025 · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $40.88, a high estimate of $48.00, and a low estimate …

nasdaq.com

$39.83
OFF

Where NewAmsterdam Pharma Stands With Analysts

3 weeks from now

Dec 30, 2024 · In the assessment of 12-month price targets, analysts unveil insights for NewAmsterdam Pharma, presenting an average target of $39.83, a high estimate of $48.00, …

benzinga.com

$34.14
OFF

NewAmsterdam Pharma Company N.V. (NAMS) Stock Forecast

3 weeks from now

NewAmsterdam Pharma (NAMS) has a price target of $34.14 with a forecast range of $27.95-$46.59 from 11 Wall St analysts. Expert stock predictions & projections.

tickernerd.com

$40.00
OFF

RBC Capital Sticks To Their Buy Rating For NewAmsterdam Pharma …

3 weeks from now

6 days ago · RBC Capital analyst Leonid Timashev maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report) today and set a price target of $40.00. The …

businessinsider.com

$47
OFF

NewAmsterdam Pharma Price Target Raised To $47 From $35 At

3 weeks from now

Dec 11, 2024 · Scotiabank analyst George Farmer raised the firm’s price target on NewAmsterdam Pharma (NAMS) to $47 from $35 and keeps an Outperform rating on the …

nasdaq.com

$2
OFF

NewAmsterdam Pharma's SWOT Analysis: Obicetrapib Stock Shows …

3 weeks from now

5 days ago · NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a biopharmaceutical company with a market capitalization of $2.3 billion focused on developing cardiovascular …

investing.com

$39.80
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Receives $39.80 …

3 weeks from now

Jan 20, 2025 · Piper Sandler reaffirmed an "overweight" rating and set a $37.00 price target on shares of NewAmsterdam Pharma in a report on Monday, September 23rd. Scotiabank …

marketbeat.com

$35.00
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Trading Up 4.1

3 weeks from now

2 days ago · A number of brokerages have issued reports on NAMS. Scotiabank boosted their price target on NewAmsterdam Pharma from $35.00 to $47.00 and gave the company a …

marketbeat.com

FAQs about NewAmsterdam Pharma (NAMS) Stock Forecast & Price Target Coupon?

What are the target prices for newamsterdam pharma's stock?

4 equities research analysts have issued 12 month target prices for NewAmsterdam Pharma's stock. Their NAMS share price forecasts range from $19.00 to $24.00. On average, they predict the company's share price to reach $21.67 in the next year. This suggests a possible upside of 50.7% from the stock's current price. ...

What is the upside for newamsterdam Pharma?

According to analysts' consensus price target of $21.67, NewAmsterdam Pharma has a forecasted upside of 49.7% from its current price of $14.47. NewAmsterdam Pharma has only been the subject of 1 research reports in the past 90 days. ...

How much does newamsterdam Pharma make?

NewAmsterdam Pharma (NASDAQ:NAMS) has a market capitalization of $255.25 million and generates $102.74 million in revenue each year. How can I contact NewAmsterdam Pharma? NewAmsterdam Pharma's mailing address is TWO UNION SQUARE 601 UNION STREET SUITE 3200, SEATTLE WA, 98101. ...